The University of Chicago Header Logo

Connection

Geoffrey Greene to Estradiol

This is a "connection" page, showing publications Geoffrey Greene has written about Estradiol.
Connection Strength

1.154
  1. Structural plasticity in the oestrogen receptor ligand-binding domain. EMBO Rep. 2007 Jun; 8(6):563-8.
    View in: PubMed
    Score: 0.279
  2. The effects of 17ß-estradiol and a selective estrogen receptor modulator, bazedoxifene, on ovarian carcinogenesis. Gynecol Oncol. 2012 Jan; 124(1):134-41.
    View in: PubMed
    Score: 0.095
  3. Modulation of alphaCaMKII signaling by rapid ERalpha action. Brain Res. 2008 Jul 30; 1222:1-17.
    View in: PubMed
    Score: 0.075
  4. An estrogen receptor-alpha knock-in mutation provides evidence of ligand-independent signaling and allows modulation of ligand-induced pathways in vivo. Endocrinology. 2008 Jun; 149(6):2970-9.
    View in: PubMed
    Score: 0.074
  5. Monoclonal antibody recognition of multiple forms of estrogen receptor tagged with [125I]methoxy-iodovinyl estradiol in ovarian carcinomas. J Clin Endocrinol Metab. 1985 Sep; 61(3):412-7.
    View in: PubMed
    Score: 0.062
  6. The Structure-Function Relationship of Angular Estrogens and Estrogen Receptor Alpha to Initiate Estrogen-Induced Apoptosis in Breast Cancer Cells. Mol Pharmacol. 2020 07; 98(1):24-37.
    View in: PubMed
    Score: 0.043
  7. Estrogen inhibits vascular smooth muscle cell-dependent adventitial fibroblast migration in vitro. Circulation. 1999 Oct 12; 100(15):1639-45.
    View in: PubMed
    Score: 0.041
  8. Antagonists for Constitutively Active Mutant Estrogen Receptors: Insights into the Roles of Antiestrogen-Core and Side-Chain. ACS Chem Biol. 2018 12 21; 13(12):3374-3384.
    View in: PubMed
    Score: 0.039
  9. Activating ESR1 Mutations Differentially Affect the Efficacy of ER Antagonists. Cancer Discov. 2017 03; 7(3):277-287.
    View in: PubMed
    Score: 0.034
  10. Analysis of the structural core of the human estrogen receptor ligand binding domain by selective proteolysis/mass spectrometric analysis. Biochemistry. 1995 Oct 03; 34(39):12605-15.
    View in: PubMed
    Score: 0.031
  11. Molecular characterization by mass spectrometry of the human estrogen receptor ligand-binding domain expressed in Escherichia coli. Mol Endocrinol. 1995 Jun; 9(6):647-58.
    View in: PubMed
    Score: 0.031
  12. Prolactin activates ERa in the absence of ligand in female mammary development and carcinogenesis in vivo. Endocrinology. 2013 Dec; 154(12):4483-92.
    View in: PubMed
    Score: 0.027
  13. Demonstration of steroid hormone receptors and steroid action in primary cultures of rat glial cells. J Steroid Biochem Mol Biol. 1992 Mar; 41(3-8):621-31.
    View in: PubMed
    Score: 0.024
  14. The limits of the cellular capacity to mediate an estrogen response. Mol Endocrinol. 1992 Feb; 6(2):157-67.
    View in: PubMed
    Score: 0.024
  15. Construction of cell lines that express high levels of the human estrogen receptor and are killed by estrogens. Mol Endocrinol. 1990 Oct; 4(10):1465-73.
    View in: PubMed
    Score: 0.022
  16. Subcellular distribution of estrogen receptor and progesterone receptor with and without specific ligand. Am J Pathol. 1989 Nov; 135(5):857-64.
    View in: PubMed
    Score: 0.021
  17. Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors. Mol Endocrinol. 1989 Feb; 3(2):295-304.
    View in: PubMed
    Score: 0.020
  18. Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells. Science. 1988 Jul 01; 241(4861):81-4.
    View in: PubMed
    Score: 0.019
  19. Regulation of progesterone receptor messenger ribonucleic acid and protein levels in MCF-7 cells by estradiol: analysis of estrogen's effect on progesterone receptor synthesis and degradation. Endocrinology. 1988 Mar; 122(3):935-44.
    View in: PubMed
    Score: 0.018
  20. CBP Is a dosage-dependent regulator of nuclear factor-kappaB suppression by the estrogen receptor. Mol Endocrinol. 2008 Feb; 22(2):263-72.
    View in: PubMed
    Score: 0.018
  21. Comparison of immunocytochemical and steroid-binding assays for estrogen receptor in human breast tumors. Cancer Res. 1985 Jan; 45(1):293-304.
    View in: PubMed
    Score: 0.015
  22. Plasma membrane estrogen receptors exist and functions as dimers. Mol Endocrinol. 2004 Dec; 18(12):2854-65.
    View in: PubMed
    Score: 0.014
  23. Differences between estrogen- and antiestrogen-estrogen receptor complexes from human breast tumors identified with an antibody raised against the estrogen receptor. Cancer Res. 1984 Mar; 44(3):1012-8.
    View in: PubMed
    Score: 0.014
  24. Interaction of [3H] estradiol - and [3H] monohydroxytamoxifen-estrogen receptor complexes with a monoclonal antibody. Breast Cancer Res Treat. 1983; 3(3):267-77.
    View in: PubMed
    Score: 0.013
  25. Monoclonal antibodies to human estrogen receptor. Proc Natl Acad Sci U S A. 1980 Sep; 77(9):5115-9.
    View in: PubMed
    Score: 0.011
  26. Antibodies to estrophilin: comparison between rabbit and goat antisera. J Steroid Biochem. 1979 Jul; 11(1A):333-41.
    View in: PubMed
    Score: 0.010
  27. Titration by estrogen receptor activation function-2 of targets that are downstream from coactivators. Mol Endocrinol. 1999 Jun; 13(6):897-909.
    View in: PubMed
    Score: 0.010
  28. The immunoendocrinology of estrophilin. Adv Exp Med Biol. 1979; 117:1-16.
    View in: PubMed
    Score: 0.010
  29. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature. 1997 Oct 16; 389(6652):753-8.
    View in: PubMed
    Score: 0.009
  30. Antibodies to estrogen receptor: immunochemical similarity of estrophilin from various mammalian species. Proc Natl Acad Sci U S A. 1977 Sep; 74(9):3681-5.
    View in: PubMed
    Score: 0.009
  31. Expression of an estrogen receptor by human coronary artery and umbilical vein endothelial cells. Circulation. 1996 Sep 15; 94(6):1402-7.
    View in: PubMed
    Score: 0.008
  32. Human estrogen receptor bound to an estrogen response element bends DNA. Mol Endocrinol. 1993 Mar; 7(3):331-40.
    View in: PubMed
    Score: 0.007
  33. Estrogen and progestin receptors and aromatase activity in rhesus monkey prostate. Endocrinology. 1988 Nov; 123(5):2312-22.
    View in: PubMed
    Score: 0.005
  34. Estrogen receptors in the nuclear matrix: direct demonstration using monoclonal antireceptor antibody. Endocrinology. 1987 May; 120(5):1851-7.
    View in: PubMed
    Score: 0.004
  35. Selection and characterization of a breast cancer cell line resistant to the antiestrogen LY 117018. Endocrinology. 1985 Oct; 117(4):1409-17.
    View in: PubMed
    Score: 0.004
  36. Immunocytochemical localization of estrogen receptors in the macaque reproductive tract with monoclonal antiestrophilins. Endocrinology. 1984 Jun; 114(6):2002-14.
    View in: PubMed
    Score: 0.004
  37. Estrogen receptor transformation in MCF-7 breast cancer cells: characterization by immunochemical and sedimentation analyses. Endocrinology. 1984 Jan; 114(1):296-8.
    View in: PubMed
    Score: 0.003
  38. Effect of antibodies to estrogen receptor on the binding of 3H-labeled antiestrogens and androstanediol in the uterus. Endocrinology. 1982 Apr; 110(4):1355-61.
    View in: PubMed
    Score: 0.003
  39. Receptors reconsidered: a 20-year perspective. Recent Prog Horm Res. 1982; 38:1-40.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.